E3 ubiquitin-protein ligase tripartite motif containing 34 (TRIM34)

E3 ubiquitin-protein ligase tripartite motif containing 34 (TRIM34) is a member of the TRIM protein family characterized by a tripartite motif: RING domain (zinc-binding), two B-box type zinc finger domains, and a coiled-coil region. TRIM34 is upregulated by interferon and contributes to innate immunity, acting as a capsid-specific restriction factor that limits the infectivity of certain non-host-adapted retroviruses in partnership with TRIM5α. Its RING domain provides E3 ubiquitin ligase activity, potentially facilitating protein degradation or downstream immune signaling. TRIM34 also promotes apoptosis by enhancing mitochondrial depolarization and cytochrome c release and has a role in cell fusion and formation of multinucleated giant epithelial cells. Disease associations include prostate cancer, epilepsy, and functional roles in viral infection defense (especially for mutated HIV-1 and SIV capsids). There are no drugs targeting this protein, nor is it used clinically as a biomarker. Its functional interaction with TRIM5α suggests an evolving antiviral role in primates, but TRIM34 itself is highly conserved, with less evidence for direct pathogen-driven adaptation.

Other names

TRIM34IFP1RNF21Interferon-responsive finger protein 1Ring finger protein 21

Not applicable. TRIM34 is not a direct target of approved drugs, but it restricts viral infection via ubiquitin-mediated degradation and participates in immune signaling pathways.